“Top 100 startups to invest in” – Challenges Magazine

April 2017. Weekly business magazine Challenges features Acticor Biotech in its special report on the “Top 100 startups to invest in”.

Download full text article (PDF, French)

Read next in 'Media Coverage'

• Acticor Biotech, a key R&D deal after a successful funding round for the treatment in the acute phase of ischemic stroke
• Biotech Finances: “Twice rewarded Acticor to raise funds again”
• Biotech Finances: “Acticor moves forward and comes back to crowdfunding!”
• BioPharmAnalyses.fr: French crowdfunding supports Acticor Biotech
• Les Echos.fr: Crowdfunding: new platforms, new projects